Zimmer Biomet Holdings Operating Income 2011-2025 | ZBH
Zimmer Biomet Holdings annual/quarterly operating income history and growth rate from 2011 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Zimmer Biomet Holdings operating income for the quarter ending June 30, 2025 was $300M, a 14.58% decline year-over-year.
- Zimmer Biomet Holdings operating income for the twelve months ending June 30, 2025 was $1.261B, a 1.87% increase year-over-year.
- Zimmer Biomet Holdings annual operating income for 2024 was $1.286B, a 0.63% increase from 2023.
- Zimmer Biomet Holdings annual operating income for 2023 was $1.278B, a 83.5% increase from 2022.
- Zimmer Biomet Holdings annual operating income for 2022 was $0.696B, a 19.06% decline from 2021.
|
Zimmer Biomet Holdings Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $1,286 |
| 2023 | $1,278 |
| 2022 | $696 |
| 2021 | $860 |
| 2020 | $83 |
| 2019 | $1,138 |
| 2018 | $34 |
| 2017 | $799 |
| 2016 | $821 |
| 2015 | $467 |
| 2014 | $1,037 |
| 2013 | $1,069 |
| 2012 | $1,047 |
| 2011 | $1,024 |
| 2010 | $917 |
|
Zimmer Biomet Holdings Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | $300 |
| 2025-03-31 | $292 |
| 2024-12-31 | $389 |
| 2024-09-30 | $280 |
| 2024-06-30 | $351 |
| 2024-03-31 | $266 |
| 2023-12-31 | $354 |
| 2023-09-30 | $267 |
| 2023-06-30 | $330 |
| 2023-03-31 | $327 |
| 2022-12-31 | $-28 |
| 2022-09-30 | $245 |
| 2022-06-30 | $281 |
| 2022-03-31 | $198 |
| 2021-12-31 | $134 |
| 2021-09-30 | $243 |
| 2021-06-30 | $225 |
| 2021-03-31 | $259 |
| 2020-12-31 | $412 |
| 2020-09-30 | $299 |
| 2020-06-30 | $-172 |
| 2020-03-31 | $-456 |
| 2019-12-31 | $337 |
| 2019-09-30 | $246 |
| 2019-06-30 | $205 |
| 2019-03-31 | $350 |
| 2018-12-31 | $-791 |
| 2018-09-30 | $223 |
| 2018-06-30 | $296 |
| 2018-03-31 | $305 |
| 2017-12-31 | $-40 |
| 2017-09-30 | $211 |
| 2017-06-30 | $280 |
| 2017-03-31 | $348 |
| 2016-12-31 | $179 |
| 2016-09-30 | $196 |
| 2016-06-30 | $202 |
| 2016-03-31 | $246 |
| 2015-12-31 | $213 |
| 2015-09-30 | $116 |
| 2015-06-30 | $-132 |
| 2015-03-31 | $270 |
| 2014-12-31 | $221 |
| 2014-09-30 | $255 |
| 2014-06-30 | $261 |
| 2014-03-31 | $300 |
| 2013-12-31 | $348 |
| 2013-09-30 | $212 |
| 2013-06-30 | $210 |
| 2013-03-31 | $298 |
| 2012-12-31 | $201 |
| 2012-09-30 | $249 |
| 2012-06-30 | $302 |
| 2012-03-31 | $296 |
| 2011-12-31 | $201 |
| 2011-09-30 | $267 |
| 2011-06-30 | $259 |
| 2011-03-31 | $297 |
| 2010-12-31 | $123 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $17.585B | $7.679B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.907B | 25.23 |
| EssilorLuxottica (ESLOY) | France | $167.835B | 0.00 |
| Boston Scientific (BSX) | United States | $149.593B | 34.21 |
| Stryker (SYK) | United States | $135.768B | 26.96 |
| Medtronic (MDT) | Ireland | $118.854B | 16.76 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.878B | 0.00 |
| Agilent Technologies (A) | United States | $41.493B | 26.85 |
| ResMed (RMD) | United States | $36.500B | 25.26 |
| GE HealthCare Technologies (GEHC) | United States | $33.472B | 16.01 |
| Koninklijke Philips (PHG) | Netherlands | $27.202B | 17.77 |
| Terumo (TRUMY) | Japan | $24.340B | 28.84 |
| Insulet (PODD) | United States | $22.536B | 69.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.234B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.124B | 7.37 |
| Bio-Rad Laboratories (BIO) | United States | $8.292B | 29.81 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| ICU Medical (ICUI) | United States | $3.437B | 21.82 |
| Lantheus Holdings (LNTH) | United States | $3.361B | 10.24 |
| Haemonetics (HAE) | United States | $3.299B | 14.68 |
| Envista Holdings (NVST) | United States | $3.297B | 18.92 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.907B | 13.26 |
| LeMaitre Vascular (LMAT) | United States | $1.992B | 40.09 |
| Curaleaf Holdings (CURLF) | Canada | $1.977B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.961B | 4.91 |
| Phibro Animal Health (PAHC) | United States | $1.858B | 18.56 |
| Green Thumb Industries (GTBIF) | United States | $1.612B | 70.64 |
| AtriCure (ATRC) | United States | $1.590B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.471B | 0.00 |
| Neogen (NEOG) | United States | $1.382B | 26.50 |
| Kestra Medical Technologies (KMTS) | United States | $1.359B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.340B | 8.62 |
| AdaptHealth (AHCO) | United States | $1.272B | 18.43 |
| BioLife Solutions (BLFS) | United States | $1.266B | 375.57 |
| InMode (INMD) | Israel | $0.923B | 10.43 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.792B | 0.00 |
| Valneva SE (VALN) | France | $0.764B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.500B | 17.23 |
| SNDL (SNDL) | Canada | $0.491B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.474B | 0.00 |
| Evolus (EOLS) | United States | $0.457B | 0.00 |
| Omeros (OMER) | United States | $0.449B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.438B | 0.00 |
| CeriBell (CBLL) | United States | $0.437B | 0.00 |
| Surmodics (SRDX) | United States | $0.391B | 0.00 |
| Cerus (CERS) | United States | $0.307B | 0.00 |
| Brainsway (BWAY) | Israel | $0.306B | 62.00 |
| Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.294B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.263B | 155.67 |
| High Tide (HITI) | Canada | $0.262B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.254B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.251B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.249B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.243B | 19.36 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Owens & Minor (OMI) | United States | $0.228B | 2.29 |
| Organigram Global (OGI) | Canada | $0.222B | 0.00 |
| Exagen (XGN) | United States | $0.214B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.210B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.199B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 16.18 |
| FitLife Brands (FTLF) | United States | $0.174B | 21.46 |
| OraSure Technologies (OSUR) | United States | $0.167B | 0.00 |
| Apyx Medical (APYX) | United States | $0.157B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.140B | 0.00 |
| Biote (BTMD) | United States | $0.122B | 4.92 |
| Sharps Technology (STSS) | United States | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.106B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 13.49 |
| MacroGenics (MGNX) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.062B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.00 |
| Nephros (NEPH) | United States | $0.046B | 33.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Jin Medical (ZJYL) | China | $0.041B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Zynex (ZYXI) | United States | $0.036B | 0.00 |
| Bonk (BNKK) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.65 |
| Modular Medical (MODD) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |